IRCT201606237080N4已完成未知
The effect of mesalazine in comparison with placebo in uncomplicated diverticulosis with abdominal symptoms
Vice Chancellor for research of Babol University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40 years 至 70 years（—）
- 性别
- All
入选标准
- •the patients between 40 to 70 years old that have chronic abdominal pain and colonoscopy or barium enema are done for them and based on clinical symptoms and colonoscopy and radiology; the diagnosis of diverticulosis is arisen for them.
- •Exclusion criteria: age below 40 and above 70; patients with history of abdominal surgery; musculoskeletal disease; spinal disorders; gallbladder stone; renal stone; bowel motility disease and inflammatory bowel disease.
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Evaluation of the role of mesalazine in the treatment of diverticular disease of the colon and irritable colon syndrome: A randomised double blind placebo controlled clinical study - NDIrritable bowel Syndrome Diverticular disease of the colonMedDRA version: 9.1Level: LLTClassification code 10009993MedDRA version: 9.1Level: LLTClassification code 10023004EUCTR2008-004228-22-ITSOFAR SPA
进行中（未招募）
1 期
Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D). - Mesalazine for the treatment of IBS-DDiarrhoea-predominant irritable bowel syndromeMedDRA version: 14.0 Level: LLT Classification code 10060849 Term: Diarrhoea predominant irritable bowel syndrome System Organ Class: 10017947 - Gastrointestinal disordersEUCTR2010-018340-14-GBniversity of Nottingham136
招募中
3 期
The combined effect of mesalazine-crocin in the treatment of inflammatory bowel diseaseUlcerative colitisIRCT20230511058153N1Shahre-kord University of Medical Sciences40
已完成
2 期
Mesalazine in chronic idiopathic urticariaChronic Idiopathic urticaria.Idiopathic UrticariaIRCT138710041520N1Shiraz University of Medical Sciences - Vice Chancellor for Research Affairs30
已完成
不适用
Clinical study for the efficacy of mesalazine for the treatment of small bowel injury caused by non-steroidal anti-inflammatory drugs(NSAIDs).Patients with rheumatoid arthritis with anemia taking NSAIDsJPRN-UMIN000005362Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine13